Highlights
NASDAQ: KNSA       Kiniksa Pharmaceuticals Ltd
Last Price Today's Change   Day's Range   Trading Volume
10.61   +0.64 (6.42%)  10.41 - 11.75  386,900

Overview

 
Avg Volume (4 weeks):255,040
4 Weeks Range:6.28 - 11.75
4 Weeks Price Volatility (%):
79.16%
52 Weeks Range:5.01 - 28.90
52 Weeks Price Volatility (%):
23.44%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases.Its clinical-stage product candidates include Rilonacept, which is in Phase II clinical trials for the treatment of recurrent pericarditis, a debilitating inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody for the treatment of giant cell arteritis; and KPL-716, KPL-045, KPL-404 are other monoclonal antibodies.

  Be the first to like this.
 


 

4706  3347  638  230 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GDX 26.97-0.65 
 CHK 0.76+0.041 
 EEM 43.07+0.25 
 BAC 33.67+0.58 
 GE 11.10+0.31 
 SPY 314.87+2.85 
 XOP 21.23+0.74 
 VIAB 24.22+0.75 
 ONTX 0.35+0.058 
Partners & Brokers